[HTML][HTML] Reduced graphene oxide decorated with gold nanoparticle as signal amplification element on ultra-sensitive electrochemiluminescence determination of …

B Khalilzadeh, N Shadjou, H Afsharan… - BioImpacts …, 2016 - ncbi.nlm.nih.gov
BioImpacts: BI, 2016ncbi.nlm.nih.gov
An external file that holds a picture, illustration, etc. Object name is bi-6-135-g015. jpg
Introduction: Growing demands for ultrasensitive biosensing have led to the development of
numerous signal amplification strategies. In this report, a novel electrochemiluminescence
(ECL) method was developed for the detection and determination of caspase-3 activity
based on reduced graphene oxide sheets decorated by gold nanoparticles as signal
amplification element and horseradish peroxidase enzyme (HRP) as ECL intensity …
Abstract
An external file that holds a picture, illustration, etc. Object name is bi-6-135-g015. jpg
Introduction: Growing demands for ultrasensitive biosensing have led to the development of numerous signal amplification strategies. In this report, a novel electrochemiluminescence (ECL) method was developed for the detection and determination of caspase-3 activity based on reduced graphene oxide sheets decorated by gold nanoparticles as signal amplification element and horseradish peroxidase enzyme (HRP) as ECL intensity enhancing agent.
Methods: The ECL intensity of the luminol was improved by using the streptavidin coated magnetic beads and HRP in the presence of hydrogen peroxide. The cleavage behavior of caspase-3 was characterized by cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS) techniques using biotinylated peptide (DEVD containing peptide) which was coated on reduced graphene oxide decorated with gold nanoparticle. The surface modification of graphene oxide was successfully confirmed by FTIR, UV-vis and x-ray spectroscopy.
Results: ECL based biosensor showed that the linear dynamic range (LDR) and the lower limit of quantification (LLOQ) were 0.5-100 and 0.5 femtomolar (fM), respectively. Finally, the performance of the engineered peptide based biosensor was validated in the A549 cell line as real samples.
Conclusion: The prepared peptide based biosensor could be considered as an excellent candidate for early detection of apoptosis, cell turnover, and cancer related diseases.
ncbi.nlm.nih.gov
以上显示的是最相近的搜索结果。 查看全部搜索结果